Effective as of July 10, 2023, MusclePharm Corporation terminated Chief Financial Officer, Gary Shirshac. There are no family relationships between Mr. Shirshac and any other director or officer of the Company. There are no transactions in which Mr. Shirshac has an interest requiring disclosure under Item 404(a) of Regulation S-K. Separately, on December 15, 2022, the Company filed for protection under Chapter 11 of the United States Bankruptcy Code before the United States Bankruptcy Court for the District of Nevada, Case No.

22-14422 ? NMC. Attached hereto are copies of the Monthly Operating Reports filed in the bankruptcy case.